НовостиBenzingaJP Morgan Maintains Overweight on BeOne Medicines, Raises Price Target to $445 JP Morgan Maintains Overweight on BeOne Medicines, Raises Price Target to $445 Benzinga 2026.10.01 18:42 (GMT+0) Открыть на Benzinga Другие новости